| Oct 1, 2025 | Foundation Health | $20.0M Series A | Define Ventures | Calm/Storm Ventures, Y Combinator, Vanderbilt University |
| Sep 30, 2025 | Visana Health | $24.0M Series A | — | Cigna Ventures, Flare Capital Partners, Frist Cressey Ventures |
| Sep 4, 2025 | Octave Bioscience | $51.1M Debt / Series C | — | Bluecross Blueshield Venture Partners, Brook Byers, Casdin Capital, Hikma Ventures, Merck, Northpond Ventures, Novartis, Section 32, Silicon Valley Bank, Valhalla Charitable Foundation |
| Feb 15, 2024 | Freenome | $254.0M Other Equity | Matt Sause | American Cancer Society, Andreessen Horowitz, ARK Invest, ArrowMark Partners, Bain Capital Life Sciences, Data Collective, Eventide Asset Management, Perceptive Advisors, Polaris Partners, Pura Vida Investments, Mark A. Gardner, RA Capital Management, Sands Capital, Section 32, Squarepoint Capital, T. Rowe Price Associates |
| Sep 1, 2023 | Cylinder | $31.0M Series B | Health Catalyst Capital | 7wire Ventures, Digitalis Ventures, Hubrix Ventures, Mercato Partners, L.d. Salmanson, Distributed Ventures, Human Capital, SemperVirens |
| Jun 2, 2023 | Axuall, Inc. | $20.0M Series B | Ryan Collins | Ajay Kumar, AV8 Ventures, Epsilon Health Investors, Flare Capital Partners, Hartford Healthcare, Inhealth Ventures, JumpStart Ventures, Chris Franklin, M25, UH Ventures |
| Apr 1, 2023 | CTRL Therapeutics | $10.0M Seed | General Catalyst | ARCH Venture Partners, F Prime Capital, FTX Ventures, LUX Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan Mccabe, Karim Atiyeh, Scott Belsky, Facit |
| Nov 1, 2022 | Maven Clinic | $90.0M Series E | General Catalyst | Addition, Andreessen Horowitz, Dragoneer Investment Group, Forerunner Ventures, Khosla Ventures, LUX Capital, Mischief Venture Capital, Next Ventures, Operator Partners, Sequoia Capital, SV Angel, Y Combinator, Vivek Garipalli, CVS Health Ventures, Icon Ventures, LA Famiglia, OAK HC/FT |
| Mar 1, 2022 | Cylinder | $16.0M Series A | 7wire Ventures | Digitalis Ventures, Hubrix Ventures, L.d. Salmanson, BIG PI Ventures, Elements Health Ventures, Human Capital, Leaps BY Bayer, LifeForce Capital, NFP Ventures, SemperVirens |
| Jan 1, 2022 | Transcarent | $200.0M Series C | Kinnevik, Armaan ALI | 7wire Ventures, General Catalyst, Frederique Dame, Ingeborg Investments, Lightspeed Venture Partners, LUX Capital, Maveron, McCarthy Capital, OMERS Ventures, RED Swan Ventures, SuperAngel.Fund, The Food Loft, Tiffany, Town Hall Ventures, Vouch Insurance, XFactor Ventures, Alison Pincus, Brian Sugar, Elliott Cohen, Fidji Simo, Henry Davis, Jason Starr, JON Stein, LEV Ekster, NIK Sharma, Ally Bridge Group, Alta Partners, GreatPoint Ventures, Jove Equity Partners, Merck, Michael Dowling, Rush University Medical Center, Threshold Ventures |
| Dec 1, 2021 | Freenome | $300.0M Series D | Ellen Hukkelhoven, Peter Kolchinsky | Anzu Partners, Ameena EL Bibany, Vasudev Bailey, ARTIS Ventures, Asset Management Ventures, Bain Capital Life Sciences, Cofounders Capital, Merck Global Health Innovation Fund, Polaris Partners, Section 32, Anne Wojcicki, Timothy A. Springer, Andreessen Horowitz, ArrowMark Partners, Brightedge Ventures, Byers Capital, Catalio Capital, Data Collective, Eventide Asset Management, Farallon Capital Management, Fidelity Management & Research Company, GV, HBM Healthcare Investments, Janus Henderson Investors, Kaiser Permanente, Logos Capital, Novartis, Polaris Partners, Pura Vida Investments, Ridgeback Capital Investments, Thomas Schinecker, Rock Springs Capital, Sands Capital, Soleus Capital, Suvretta Capital Management, T. Rowe Price Associates |
| Dec 24, 2020 | SomaLogic | $81.0M Series A Extension | ELI Casdin | Amgen Ventures, Boston Millennia Partners, Farallon Capital Management, Fiscus Ventures, Foresite Capital, Janus Henderson Investors, Logos Capital, Madryn Asset Management, Monashee Investment Management, Mossrock Capital, NEC Solution Innovators, Novartis, Redmile Group, Reimagined Ventures, Revelation Partners, Soleus Capital, ROY Smythe, T. Rowe Price Associates, Ziff Capital Partners |
| Sep 10, 2020 | Recursion | $239.0M Series D | Juergen Eckhardt | Advantage Capital, Casdin Capital, Catalio Capital, Data Collective, Epic Ventures, Felicis Ventures, Laurion Capital Management, LUX Capital, Obvious Ventures, Samsara BioCapital, TWO Sigma Ventures |
| Sep 1, 2020 | Recursion Pharmaceuticals | $240.0M Series D | Juergen Eckhardt | 01 Advisors, Album VC, Dimension Capital, Advantage Capital, Casdin Capital, Catalio Capital, Epic Ventures, Felicis Ventures, Laurion Capital Management, LUX Capital, Obvious Ventures, Samsara BioCapital, TWO Sigma Ventures |
| Jul 1, 2020 | Thrive Earlier Detection | $260.0M Series B | Section 32, ELI Casdin | Acrew Capital, CRV, GreatPoint Ventures, Mubadala, Polaris Partners, Third Rock Ventures, Trucks Venture Capital, Vzvc, Bain Capital Life Sciences, Brown Advisory, Driehaus Capital Management, Janus Henderson Investors, LUX Capital, Perceptive Advisors, Rock Springs Capital, Sands Capital, T. Rowe Price Associates |
| May 28, 2020 | Syapse | $30.0M Other Equity | Zack Scott | Amgen Ventures, Ascension Ventures, Merck, Roche Finance, Safeguard Scientifics, Social Capital |
| May 1, 2020 | Syapse | $30.0M Series F | Revelation Partners | Active Capital, Ascension Ventures, Drive Capital, Esplanade Healthtech Ventures, Founders Fund, Hyde Park Venture Partners, Insight Partners, Khosla Ventures, Moonshots Capital, OAK HC/FT, Presight Capital, Social Capital, Tiger Global Management, Transformation Capital, Vensana Capital, Joanne Bradford, Nirav Tolia, Will Szczerbiak, Amgen Ventures, Merck, Roche Finance, Safeguard Scientifics |
| Jul 15, 2019 | Recursion | $121.0M Series C | — | AME Cloud Ventures, CRV, Data Collective, Epic Ventures, Felicis Ventures, LUX Capital, Mubadala Capital, Obvious Ventures, Texas Tech University System, TWO Sigma Ventures, University OF Minnesota |
| Jul 1, 2019 | Recursion Pharmaceuticals | $120.0M Series C | — | 01 Advisors, Album VC, Dimension Capital, Gaingels, Menlo Ventures, AME Cloud Ventures, CRV, Data Collective, Epic Ventures, Felicis Ventures, LUX Capital, Mubadala Capital, Obvious Ventures, Texas Tech University System, TWO Sigma Ventures, University OF Minnesota |
| Apr 1, 2019 | Redox | $33.0M Series C | Battery Ventures | Headwater Ventures, RRE Ventures, Duncan Gills, .406 Ventures |
| Jun 1, 2018 | Zebra Medical Vision | $30.0M Series C | — | ACME Capital, AIX Ventures, Dell Technologies Capital, DNX Ventures, Founders Fund, Khosla Ventures, Menlo Ventures, OurCrowd, Polychain Capital, Phil Libin, Shervin Pishevar, FEI FEI LI, Richard Socher, Morris Kahn, Dolby Family Ventures, Johnson & Johnson Innovation, NVIDIA |
| Jan 16, 2018 | Tissue Analytics | $5.0M Series A | David Kim, MD | Dreamit Ventures, Molnlycke Health Care, Penn Medicine, Tencent Holdings |
| Nov 1, 2017 | Syapse | $30.0M Series D | — | Active Capital, Ascension Ventures, Drive Capital, GE Ventures, Hyde Park Venture Partners, Khosla Ventures, Lightspeed Venture Partners, Moonshots Capital, OAK HC/FT, Social Capital, Tiger Global Management, Transformation Capital, Joanne Bradford, Nirav Tolia, Will Szczerbiak, Amgen Ventures, Glen DE Vries, Merck, Roche, Safeguard Scientifics |
| Jul 1, 2017 | Circulation | $11.0M Series A | — | Flare Capital Partners, Flybridge, Boston Children's Hospital, Echo Health Ventures, Humana, NextGen Venture Partners, James Lindstrom |
| Sep 5, 2013 | Ingram Medical | $30.0M Series B | Mercato Partners | Stepstone Group |
